2024-09-02 - Analysis Report
## Lilly (LLY) Stock Analysis Report

**Company Overview:** Lilly is a leading pharmaceutical company that develops, manufactures, and markets a wide range of prescription medicines.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return (LLY):** 571.94%
* **Cumulative Return (VOO):** 89.66%
* **Current Deviation:** 482.28%
* **Relative Deviation:** 100.0%

Lilly has significantly outperformed the S&P 500, showing a 482.28% higher cumulative return. This places Lilly at the highest historical performance level compared to the S&P 500 within the observed period.

**2. Recent Price Movements:**

* **Closing Price:** $960.02
* **5-Day Moving Average:** $950.83
* **20-Day Moving Average:** $907.01
* **60-Day Moving Average:** $888.73

Lilly's stock price is currently trading above all three moving averages, suggesting a potential short-term uptrend.

**3. Technical Indicators:**

* **RSI:** 78.82
* **PPO:** 0.36
* **Delta_Previous_Relative_Divergence:** 18.98
* **Expected Return:** 0.0%

The RSI indicates that Lilly is currently in overbought territory, which could signal a potential correction. The PPO suggests a positive momentum, but the high RSI raises concerns about a potential pullback. The positive Delta_Previous_Relative_Divergence signals a short-term bullish trend. The expected return of 0.0% indicates a potential for future growth, although it is important to note that this is just an estimate.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | $11.30 B |
| 2024-04-30 | 2.49 | $8.77 B |
| 2023-11-02 | -0.06 | $9.50 B |
| 2023-08-08 | 1.96 | $8.31 B |
| 2024-08-08 | 1.96 | $8.31 B |

Lilly's recent earnings have shown strong growth, with the most recent earnings report exceeding analysts' expectations. The company has consistently grown its revenue and EPS, showcasing its strong financial performance.

**5. Overall Analysis:**

Lilly's strong performance, evidenced by its high cumulative return and recent price movements, suggests potential for further growth. The company's strong financials and earnings performance, coupled with positive technical indicators, suggest a bullish outlook. However, the high RSI indicates potential for a correction, and investors should monitor the stock closely.

**6. Conclusion:**

Lilly's stock appears to be in a strong position for growth, as supported by its historical performance, recent price trends, and positive financial results. While potential for correction exists due to the high RSI, the overall bullish outlook makes Lilly a potentially attractive investment opportunity for investors seeking long-term growth. 
